packageRituximab

rituximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rituximab is a monoclonal antibody used to treat B-cell blood cancers such as non-Hodgkin and chronic lymphocytic leukemia and many autoimmune conditions including rheumatoid arthritis, vasculitis, and pemphigus. It is widely used and appears on the WHO essential medicines list, with several products authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q412323 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rituximab
ATC codes:L01FA01, L01XC02
DrugBank:DB00073
Wikidata:Q412323
molar mass:143860 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown